期刊文献+

具有复合靶向抗癌功能的纳米高分子材料 被引量:44

PREPARATION OF B1-TARGET ANTICANCER DRUGSIMMUNOLOGICAL MAGNETIC ADRIAMYCIN NANOPARTICLES AND ITS EVALUATION IN VITRO
下载PDF
导出
摘要 用氧化还原法制备出具有复合靶向抗癌功能的纳米高分子材料阿霉素免疫磁性毫微粒,并对制备条件进行优化,用扫描电镜和光子相关光谱对产物进行了定性和定量表征,并进行了体外抑瘤试验和体外磁导向定位试验。 Adriamycin and anti-human mammary cancer monoclonal antibody (McAb) were conjugated to the magnetic iron-dextran nanoparticles by the periodate oxidation-borohydride reduction procedure. The conjugates were separated out by gel filtration chromatography on Sephacryl S-300 and characterized by SEM and laser scattering system. The mean diameter of nanoparticles was 216 nm and the molar ratio of Ab∶Dex∶Adr in conjugate was 1∶5∶94. The conjugates prepared by this procedure had high immunological activity evaluated by ELISA and did not flocculate in physiological buffer. The nanoparticles could well bind the cancer cells and killed 80% of them in vitro, showing that the conjugate had significant retention of biological activity of the antibody. A magnetic field was kept on the simulated blood capillaries. The nanoparticles flowed in the capillaries could be 100% retained in the magnetic area and removed if the magnetic field disappeared, showing that they had high magnetic responsibility and superparamagnetism.
作者 常津
出处 《中国生物医学工程学报》 CSCD 北大核心 1996年第2期97-101,共5页 Chinese Journal of Biomedical Engineering
基金 国家自然科学基金
关键词 免疫磁性毫微粒 阿霉素 靶向抗癌药 抗癌药 Immunological magnetic nanoparticle Adriamycin Target anticancer drug
  • 相关文献

参考文献2

共引文献1

同被引文献434

引证文献44

二级引证文献278

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部